Nargiz Noimann is a neuroscientist afounder focused on how immersive technology and AI can support cognitive resilience and emotional recovery in clinical and post treatment settings. She has more than 25 years of international experience across neuroscience, psychotechnology, and healthcare innovation, and has studied at institutions including Stanford University. Nargiz is the founder of X Technology, a UAE based healthtech company developing AI powered VR programs designed to support recovery experiences for patients and caregivers. She also leads the Scientific Research Center for Psychotechnologies in Kazakhstan, where her work explores structured approaches to mental resilience, attention, and recovery in high stress and chronic illness contexts.
When people hear dosage, they often think of medication. But dosage is a broader clinical concept. It is the structure that makes an intervention legible to clinicians, payers, and regulators. For VR therapy, dosage is the answer to simple questions that are still surprisingly inconsistent across studies and pilots.